Expansion and upgrades coming to the Lacey cancer clinic

October 8, 2024

These upgrades are critical in delivering local top-tier oncology care  

SOUTH PUGET SOUND – Investing in expansions and upgrades for our cancer services enable us to respond to the growing needs of our community,” said Chief Executive Darin Goss. “We’re providing the care close to home, while offering access to the network of services offered within the broader Providence Swedish Cancer Institute. 

Philanthropy will be a cornerstone of the project. By partnering with the community and our Foundation, we aim to secure the necessary funding to achieve our goals. Local support and philanthropic efforts will play an instrumental role in the successful completion of this project by 2028.  

Project details  

  • Enhance Patient Care: By upgrading our facilities and equipment, we can provide higher-quality, more reliable treatments. 

  • Reduce Wait Times: Additional resources will help us accommodate more patients promptly.  

  • Support Growing Demand: Expanded Oncology services will help us meet the rising needs of the community. 

Expansion of Infusion Services   

  • Infusion Chairs: Adding 8 infusion chairs and 1 injection station to better serve our patients.  

  • Compounding Capabilities: Introducing 2 additional hoods to maximize our compounding capacity.  

  • Phlebotomy Chair: Adding 1 phlebotomy chair to streamline blood draw processes.  

  • Oncology Exam Rooms: Constructing 4 new exam rooms to improve service delivery.  

Key Equipment Upgrades   

  • PET/CT Scanner: Replacing the end-of-life PET/CT scanner, to ensure the best diagnostics in the area for our patients.  

  • Linear Accelerator: Replacing the Linear Accelerator to meet industry standards and enhance treatment reliability.  

  • CT Simulator: Replacing the CT simulator for improved capability and accuracy.  

“We are thrilled this project has been granted the “stamp of approval” by the highest levels of our organization,” said Ryan Moore, Senior Director of Oncology. “Locally, our executive team has played a crucial role in securing approval. I am so grateful for their support of our team.”  

Previous Article
CMO Message: October 2024

Next Article
Christmas in the Forest Gala Nov. 23